Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions (Q64102147)

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Partial agonists for brain GABA/benzodiazepine receptor complex

1 reference

12 December 2020

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells

1 reference

12 December 2020

Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains

1 reference

12 December 2020

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

1 reference

12 December 2020

Reduced neuropeptide Y concentrations in suicide brain

1 reference

12 December 2020

Lack of beneficial effects of l-baclofen in affective disorder.

1 reference

12 December 2020

Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy

1 reference

12 December 2020

Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants

1 reference

12 December 2020

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

1 reference

12 December 2020

Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks

1 reference

12 December 2020

Brain GABAB binding sites in depressed suicide victims

1 reference

12 December 2020

CSF somatostatin in affective illness and normal volunteers

1 reference

12 December 2020

Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock

1 reference

12 December 2020

Estrogen-induced up-regulation of gamma-aminobutyric acid receptors in the CNS of rodents

1 reference

12 December 2020

Changes in central GABAergic function following acute and repeated stress

1 reference

12 December 2020

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

1 reference

12 December 2020

Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat

1 reference

12 December 2020

Plasma GABA levels in psychiatric illness

1 reference

12 December 2020

(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

1 reference

12 December 2020

Bicuculline-insensitive gaba receptors on peripheral autonomic nerve terminals

1 reference

12 December 2020

CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa

1 reference

12 December 2020

GABA levels in CSF of patients with psychiatric disorders

1 reference

12 December 2020

Neuropeptide Y in frontal cortex is not altered in major depression

1 reference

12 December 2020

Neuropeptide Y produces anxiolytic effects in spontaneously hypertensive rats

1 reference

12 December 2020

GABAB receptor antagonists: from synthesis to therapeutic applications

1 reference

12 December 2020

A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature

1 reference

12 December 2020

The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress

1 reference

12 December 2020

Benzodiazepines as antidepressants: does GABA play a role in depression?

1 reference

12 December 2020

Benzodiazepines for depression? A review of the literature

1 reference

12 December 2020

Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients

1 reference

12 December 2020

Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects

1 reference

12 December 2020

Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

1 reference

12 December 2020

Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

1 reference

12 December 2020

Immunohistochemical localization of the neural cannabinoid receptor in rat brain

1 reference

12 December 2020

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1 reference

12 December 2020

Effects of antidepressant treatment on neuroactive steroids in major depression

1 reference

12 December 2020

Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery

1 reference

12 December 2020

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt

1 reference

12 December 2020

Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression

1 reference

12 December 2020

Effect of CGP 36742 on the extracellular level of neurotransmitter amino acids in the thalamus

1 reference

12 December 2020

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues

1 reference

12 December 2020

The GABA(B) receptor antagonist CGP36742 improves learned helplessness in rats

1 reference

12 December 2020

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

1 reference

12 December 2020

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy

1 reference

12 December 2020

Antidepressant effects of ketamine in depressed patients

1 reference

12 December 2020

GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats

1 reference

12 December 2020

Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues

1 reference

12 December 2020

GABAB-RI receptors in serotonergic neurons: effects of baclofen on 5-HT output in rat brain

1 reference

12 December 2020

Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice.

1 reference

12 December 2020

Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.

1 reference

12 December 2020

Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test

1 reference

12 December 2020

Variations in maternal care in infancy regulate the development of stress reactivity

1 reference

12 December 2020

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures.

1 reference

12 December 2020

Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation

1 reference

12 December 2020

Corticosterone exerts site-specific and state-dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat depots

1 reference

12 December 2020

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

1 reference

12 December 2020

Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

1 reference

12 December 2020

The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders

1 reference

12 December 2020

A new benzodiazepine pharmacology.

1 reference

12 December 2020

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

1 reference

12 December 2020

The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test

1 reference

12 December 2020

Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins

1 reference

12 December 2020

Neuropeptide Y (NPY) and depression: from animal studies to the human condition

1 reference

12 December 2020

Low CSF somatostatin associated with response to nimodipine in patents with affective illness

1 reference

12 December 2020

GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase

1 reference

12 December 2020

Fluoxetine increases GABA(A) receptor activity through a novel modulatory site

1 reference

12 December 2020

NPY attenuates positive cortical DC-potential shift upon food intake in man.

1 reference

12 December 2020

Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain

1 reference

12 December 2020

Perspectives of new potential therapeutic applications of somatostatin analogs

1 reference

12 December 2020

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

1 reference

12 December 2020

Variations in maternal care alter GABA(A) receptor subunit expression in brain regions associated with fear

1 reference

12 December 2020

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

1 reference

12 December 2020

Somatostatin directly inhibits substantia gelatinosa neurons in adult rat spinal dorsal horn in vitro

1 reference

12 December 2020

GABA(B) receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro

1 reference

12 December 2020

Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability.

1 reference

12 December 2020

Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat.

1 reference

12 December 2020

Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor

1 reference

12 December 2020

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

1 reference

12 December 2020

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

1 reference

12 December 2020

Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.

1 reference

12 December 2020

Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE)

1 reference

12 December 2020

Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

1 reference

12 December 2020

In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors.

1 reference

12 December 2020

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

12 December 2020

Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel

1 reference

12 December 2020

GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent.

1 reference

12 December 2020

Molecular evolution of NPY receptor subtypes

1 reference

12 December 2020

Interneurons of the neocortical inhibitory system

1 reference

12 December 2020

SGS742: the first GABA(B) receptor antagonist in clinical trials

1 reference

12 December 2020

Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man.

1 reference

12 December 2020

Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.

1 reference

12 December 2020

Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala

1 reference

12 December 2020

Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram

1 reference

12 December 2020

GABAA receptor gamma 2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines.

1 reference

12 December 2020

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

1 reference

12 December 2020

Agonistic properties of cannabidiol at 5-HT1a receptors

1 reference

12 December 2020

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

12 December 2020

Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

1 reference

12 December 2020

Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat.

1 reference

12 December 2020

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder

1 reference

12 December 2020

Effects of cannabinoids on neurotransmission.

1 reference

12 December 2020

Inhibitory effect of somatostatin on inflammation and nociception

1 reference

12 December 2020

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

12 December 2020

Low plasma BDNF is associated with suicidal behavior in major depression

1 reference

12 December 2020

Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents

1 reference

12 December 2020

GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression

1 reference

12 December 2020

Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons.

1 reference

12 December 2020

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy

1 reference

12 December 2020

Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress.

1 reference

12 December 2020

Patterns of gene expression in the limbic system of suicides with and without major depression

1 reference

12 December 2020

GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

1 reference

12 December 2020

Fluoxetine partly exerts its actions through GABA: a neurochemical evidence

1 reference

12 December 2020

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression

1 reference

12 December 2020

The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice

1 reference

12 December 2020

Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats

1 reference

12 December 2020

Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.

1 reference

12 December 2020

Effects of GABAB receptor ligands in animal tests of depression and anxiety.

1 reference

12 December 2020

Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia.

1 reference

12 December 2020

S-ketamine and GABA-A-receptor interaction in humans: an exploratory study with I-123-iomazenil SPECT.

1 reference

12 December 2020

Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder

1 reference

12 December 2020

Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence.

1 reference

12 December 2020

SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake

1 reference

12 December 2020

Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis

1 reference

12 December 2020

Surveillance for violent deaths--national violent death reporting system, 16 States, 2006.

1 reference

12 December 2020

The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression

1 reference

12 December 2020

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide

1 reference

12 December 2020

A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response

1 reference

12 December 2020

Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors

1 reference

12 December 2020

In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.

1 reference

12 December 2020

Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies

1 reference

12 December 2020

Cannabinoid CB1 receptors in rat medial prefrontal cortex are colocalized with calbindin- but not parvalbumin- and calretinin-positive GABA-ergic neurons

1 reference

12 December 2020

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.

1 reference

12 December 2020

Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression.

1 reference

12 December 2020

gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression

1 reference

12 December 2020

Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy

1 reference

12 December 2020

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

12 December 2020

Antidepressant-like properties of α2-containing GABAA receptors

1 reference

12 December 2020

GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.

1 reference

12 December 2020

The GABAergic deficit hypothesis of major depressive disorder.

1 reference

12 December 2020

Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons

1 reference

12 December 2020

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

1 reference

12 December 2020

A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression

1 reference

12 December 2020

1 reference

12 December 2020

Reduced somatostatin in subgenual anterior cingulate cortex in major depression

1 reference

12 December 2020

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

1 reference

12 December 2020

Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment

1 reference

12 December 2020

Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study

1 reference

12 December 2020

Effect of Escitalopram on GABA level and anti-oxidant markers in prefrontal cortex and nucleus accumbens of chronic mild stress-exposed albino rats

1 reference

12 December 2020

Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions

1 reference

12 December 2020

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

1 reference

12 December 2020

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

1 reference

12 December 2020

Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response

1 reference

12 December 2020

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

1 reference

12 December 2020

Depression: The Disorder and the Burden

1 reference

12 December 2020

Anxiety and depression: Mouse genetics and pharmacological approaches to the role of GABAA receptor subtypes

1 reference

12 December 2020

5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons.

1 reference

12 December 2020

Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression

1 reference

12 December 2020

Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia

1 reference

12 December 2020

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.

1 reference

12 December 2020

Different pattern of changes in calcium binding proteins immunoreactivity in the medial prefrontal cortex of rats exposed to stress models of depression

1 reference

12 December 2020

Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters

1 reference

12 December 2020

Neuropeptide Y: identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model

1 reference

12 December 2020

[Decreased occipital GABA concentrations in patients with first-episode major depressive disorder: a magnetic resonance spectroscopy study]

1 reference

12 December 2020

Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression

1 reference

12 December 2020

Alprazolam for depression

1 reference

12 December 2020

Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brain-derived neurotrophic factor

1 reference

12 December 2020

Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients

1 reference

12 December 2020

Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder

1 reference

12 December 2020

Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice

1 reference

12 December 2020

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

1 reference

12 December 2020

The differential effects of acute vs. chronic stress and their combination on hippocampal parvalbumin and inducible heat shock protein 70 expression.

1 reference

12 December 2020

New insights into the classification and nomenclature of cortical GABAergic interneurons

1 reference

12 December 2020

Serotonin modulation of cortical neurons and networks

1 reference

12 December 2020

mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling

1 reference

12 December 2020

Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain.

1 reference

12 December 2020

The ability of BDNF to modify neurogenesis and depressive-like behaviors is dependent upon phosphorylation of tyrosine residues 365/367 in the GABA(A)-receptor γ2 subunit

1 reference

12 December 2020

Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats

1 reference

12 December 2020

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex

1 reference

12 December 2020

Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice

1 reference

12 December 2020

Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

1 reference

12 December 2020

Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings

1 reference

12 December 2020

Chronic stress reduces the number of GABAergic interneurons in the adult rat hippocampus, dorsal-ventral and region-specific differences

1 reference

12 December 2020

BDNF release is required for the behavioral actions of ketamine

1 reference

12 December 2020

Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η

1 reference

12 December 2020

Somatostatin, neuronal vulnerability and behavioral emotionality

1 reference

12 December 2020

Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes.

1 reference

12 December 2020

Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants

1 reference

12 December 2020

Depression of excitatory synapses onto parvalbumin interneurons in the medial prefrontal cortex in susceptibility to stress

1 reference

12 December 2020

Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors

1 reference

12 December 2020

Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder

1 reference

12 December 2020

Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice

1 reference

12 December 2020

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

1 reference

12 December 2020

Chronic mild stress alters the somatostatin receptors in the rat brain

1 reference

12 December 2020

DREADD in parvalbumin interneurons of the dentate gyrus modulates anxiety, social interaction and memory extinction

1 reference

12 December 2020

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy

1 reference

12 December 2020

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

1 reference

12 December 2020

Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment

1 reference

12 December 2020

A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults

1 reference

12 December 2020

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

1 reference

12 December 2020

Somatostatin-expressing neurons in cortical networks.

1 reference

12 December 2020

Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction.

1 reference

12 December 2020

Sensitivity of the prefrontal GABAergic system to chronic stress in male and female mice: Relevance for sex differences in stress-related disorders.

1 reference

12 December 2020

Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors

1 reference

12 December 2020

GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits

1 reference

12 December 2020

Chronic stress affects the number of GABAergic neurons in the orbitofrontal cortex of rats.

1 reference

12 December 2020

Decrease in somatostatin-positive cell density in the amygdala of females with major depression

1 reference

12 December 2020

Electron Microscopic Analysis of Hippocampal Axo-Somatic Synapses in a Chronic Stress Model for Depression.

1 reference

12 December 2020

Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures

1 reference

12 December 2020

Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress

1 reference

12 December 2020

Prefrontal Cortex GABAergic Deficits and Circuit Dysfunction in the Pathophysiology and Treatment of Chronic Stress and Depression

1 reference

12 December 2020

Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state

1 reference

12 December 2020

Why is depression more common among women than among men?

1 reference

12 December 2020

Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator.

1 reference

12 December 2020

Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons

1 reference

12 December 2020

Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality

1 reference

12 December 2020

How do antidepressants work? New perspectives for refining future treatment approaches.

1 reference

12 December 2020

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors.

1 reference

12 December 2020

A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.

1 reference

12 December 2020

Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression

1 reference

12 December 2020

Changes in the Prefrontal Glutamatergic and Parvalbumin Systems of Mice Exposed to Unpredictable Chronic Stress

1 reference

12 December 2020

Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors

1 reference

12 December 2020

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders

1 reference

12 December 2020

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

1 reference

12 December 2020

Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives

1 reference

12 December 2020

Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine

1 reference

12 December 2020

The potential efficacy of GABAB antagonists in depression

1 reference

12 December 2020

Characterization of GABAergic marker expression in the chronic unpredictable stress model of depression

1 reference

12 December 2020

Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.

1 reference

12 December 2020

A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder

1 reference

12 December 2020

BDNF release and signaling are required for the antidepressant actions of GLYX-13.

1 reference

12 December 2020

Central neuropeptide Y plays an important role in mediating the adaptation mechanism against chronic stress in male rats

1 reference

12 December 2020

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling.

1 reference

12 December 2020

Regulation of somatostatin receptor 2 in the context of antidepressant treatment response in chronic mild stress in rat.

1 reference

12 December 2020

Altered Cortical GABA in Female Veterans with Suicidal Behavior: Sex Differences and Clinical Correlates

1 reference

12 December 2020

The Gamma-Aminobutyric Acid B Receptor in Depression and Reward

1 reference

12 December 2020

PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders.

1 reference

12 December 2020

Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex

1 reference

12 December 2020

An Emerging Circuit Pharmacology of GABA Receptors

1 reference

12 December 2020

Long-Term Stress Disrupts the Structural and Functional Integrity of GABAergic Neuronal Networks in the Medial Prefrontal Cortex of Rats.

1 reference

12 December 2020

Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis

1 reference

12 December 2020

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

1 reference

12 December 2020

Cannabinoids in depressive disorders

1 reference

12 December 2020

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

1 reference

12 December 2020

Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA receptors and (R)‑ketamine in a chronic social defeat stress model

1 reference

12 December 2020

A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems

1 reference

12 December 2020

Subregion-specific Protective Effects of Fluoxetine and Clozapine on Parvalbumin Expression in Medial Prefrontal Cortex of Chronically Isolated Rats

1 reference

12 December 2020

Hemisphere-dependent Changes in mRNA Expression of GABAA Receptor Subunits and BDNF after Intra-prefrontal Cortex Allopregnanolone Infusion in Rats

1 reference

12 December 2020

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression

1 reference

12 December 2020

Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine

1 reference

12 December 2020